References
- Akbuga J, Bergisadi N. 5-flourouracil-loaded chitosan microspheres: preparation and release characteristics. J Microencapsulation 1996; 13: 161–168
- Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. AAPS Pharm Sci Tech 2005; 6: 372–390
- Aulton ME. Pharmaceutics: The science of dosage form design. International student ed. Churchill Livingstone, London 2002; 206–211
- Baumgastner S, Kristel J, Vreer F, Vodopivec P, Zorko B. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm 2000; 195: 125–130
- Brahmankar DM, Jaiswal SB. Biopharmaceutics and pharmacokinetics: A treatise, 1st. Vallabh Prakashan, xNew Delhi 1995; 335–371
- Chiao CS, Robinson JR. Sustained-release drug delivery systems. Remington: The science and practice of industrial pharmacy, 19th ed, MA Longer, JR Robinson. Mack Publication Company, Eastern Pennsylvania 1995; II: 1660–1675
- Chien YW. Concepts and system design for rate-controlled drug delivery in novel drug delivery systems, 2nd ed. Marcel Dekker Inc, New York 1992; 1–42
- Honjec M. Ranitidine hydrochloride. Analytical profiles of drug substances, K Florey. Academic Press, New York 1986; 15: 533–561
- Joseph NJ, Laxmi S, Jayakrishnan A. A floating type oral dosage form for Piroxicam based on hollow microspheres: in vitro and in vivo evaluation in rabbits. J Control Rel 2002; 79: 71–79
- Khan GM. Controlled release oral dosage forms: some recent advances in matrix type drug delivery systems. The Sciences 2001; 1: 350–354
- Klausner EA, Lavy E, Friedman M, Hoffman A. Expandable gastroretentive dosage froms. J Control Rel 2003; 24: 143–162
- Lee TW, Robinson JR. Controlled release drug delivery systems. Remington: The science and practice of pharmacy, 20th ed, AR Gennaro. Lippincott Williams and Wilkinson, Philadelphia 2000; 1: 903–928
- Majeti M, Kumar NV. Nano and microparticles as controlled drug delivery devices. J Pharm Pharm Sci 2000; 3: 234–258
- Mathiowitz E. Encyclopedia of controlled drug delivery. John Wiley and Sons Inc, New York 1999; II: 729–731
- Orellana GI. Expert Opin. Drug Deliv. 2005; 2(3)419–433, Available online at: http://www.ingentaconect.com
- Sankar C, Mishra B. Development and in vitro evaluation of gelatin microspheres of ketorolac tromethamine for intranasal administration. Acta Pharm 2003; 53: 101–110
- Singh BN, Kim KH. Floating drug delivery systems an approach to oral controlled drug delivery via gastric retention. J Control Rel 2000; 63: 235–259
- Soppimath KS, Kulkarni AR, Aminabhavi TM. Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: preparation and release characteristics. Drug Dev Ind Pharm 2001; 27: 507–515
- Thanoo BC, Sunny MC, Jayakrishnan A. Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on gastric fluid. J Pharm Pharmacol 1993; 45: 21–24
- Vijaya RD, Medlicott N, Razzak M, Tucker IG. Microencapsulation of FITC-BSA into poly (ε-caprolactone) by a water-in-oil-in-oil solvent evaporation technique. Trends Biomater Artif Organs 2002; 15: 31–36
- Wab H, Robinson JR, Lee VH. Design of oral controlled release drug delivery systems. Controlled drug delivery fundamentals and applications, 2nd, VR Robinson, VHL Lee. Marcel Dekker, New York 1987; 418–420